Sat, Feb 28, 2015, 10:01 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Henry Schein, Inc. Message Board

  • bluecheese4u bluecheese4u Feb 25, 2008 8:24 AM Flag

    Henry Schein Reports Record Fourth Quarter and Full Year Results

    Henry Schein Reports Record Fourth Quarter and Full Year Results

    Monday February 25, 7:00 am ET
    Fourth quarter diluted EPS from continuing operations increases 19% to $0.83
    Annual diluted EPS from continuing operations increases 27%


    MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (NASDAQ: HSIC - News), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, today reported financial results for the quarter ended December 29, 2007.


    Net sales for the fourth quarter of 2007 were $1.7 billion, an increase of 16.4% compared with the fourth quarter of 2006. This increase includes 12.3% local currency growth (3.8% internally generated and 8.5% from acquisitions) and 4.1% related to foreign currency exchange. (See Exhibit A for details of sales growth.)

    Income from continuing operations for the fourth quarter of 2007 was $76.4 million or $0.83 per diluted share, up 21.3% and 18.6%, respectively, compared with the prior-year fourth quarter.

    Net income for the fourth quarter of 2007 was $78.3 million or $0.85 per diluted share. Results include income from discontinued operations of approximately $1.8 million or $0.02 per diluted share, primarily related to the gain on the sale of the Company’s specialty pharmacy business.

    “Our strong fourth quarter financial results close out a very solid year for Henry Schein,” said Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein. “For the year our Dental, Medical, International and Technology Groups each reported double-digit sales growth and market share gains, and we are proud to have once again achieved our key long-term financial objectives for internal sales growth, operating margin expansion, EPS growth and cash flow from operations.”

    Dental Group sales increased 12.8% during the fourth quarter, including 11.2% growth in local currencies (9.4% internally generated and 1.8% from acquisitions) and 1.6% growth related to foreign currency exchange. Of the 11.2% local currency growth, Dental consumable merchandise sales increased 6.5% (4.6% internal growth and 1.9% acquisition growth) and Dental equipment sales and service revenues were up 21.3% (19.6% internal growth and 1.7% acquisition growth).

    “Our Dental Group continues to be successful in delivering profitable growth and expanding our presence in the marketplace,” commented Mr. Bergman. “Fourth quarter performance was highlighted by impressive internal growth in equipment sales and service revenues, with strong gains in both traditional equipment and high-tech products.”

    Medical Group sales declined 5.5% during the fourth quarter (6.0% decline in internal growth and 0.5% acquisition growth). Medical Group sales were impacted by the timing of influenza vaccine sales which, while higher in the third quarter of 2007 due to earlier shipments, were significantly lower in the fourth quarter of 2007 when compared with the fourth quarter of 2006. Excluding sales of influenza vaccine, Medical Group sales increased 3.8% for the quarter, with 3.3% internal growth. For the year influenza vaccine sales were more than 20% higher than 2006.

    “During the fourth quarter we achieved our

    http://biz.yahoo.com/bw/080225/20080225005702.html?.v=1

 
HSIC
140.05-0.39(-0.28%)Feb 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.